semaglutide issues Compounded Safety: What You Should Know Semaglutide, a glucagon-like peptide-1 receptor

8 AriyasuH.TakayaK.IwakuraH.HosodaH.AkamizuT.AraiY.et al (2005)

The window of opportunity that the FDA describes will not remain open long, and stakeholders prescribing, receiving, or dispensing compounded semaglutide injection products need to take immediate action to plan and adapt accordingly

BIOMOD is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act

Symptom Tracking: Keep track of each clients symptoms over time, allowing for easy identification of trends and correlations between GLP-1 usage and symptom presentation

We have invested in two state-of-the-art in-house laboratories that allow us to conduct four rounds of testing, while most competitors test only one or two times